ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Mesoblast Limited

Mesoblast Limited (MSB)

2.52
0.12
(5.00%)
Closed 23 December 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.52
Bid
2.53
Offer
2.54
Volume
13,221,879
2.41 Day's Range 2.67
0.255 52 Week Range 3.09
Market Cap
Previous Close
2.40
Open
2.41
Last Trade
6100
@
2.53
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
6,624,068
Shares Outstanding
736,578,315
Dividend Yield
-
PE Ratio
-21.11
Earnings Per Share (EPS)
-0.12
Revenue
9.25M
Net Profit
-87.96M

About Mesoblast Limited

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Melbourne, Victoria, Aus
Founded
-
Mesoblast Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker MSB. The last closing price for Mesoblast was AUD2.40. Over the last year, Mesoblast shares have traded in a share price range of AUD 0.255 to AUD 3.09.

Mesoblast currently has 736,578,315 shares in issue. The market capitalisation of Mesoblast is AUD1.77 billion. Mesoblast has a price to earnings ratio (PE ratio) of -21.11.

MSB Latest News

Mesoblast Gets FDA's Special Pediatric Designation for Revascor Heart Treatment

By Dean Seal Mesoblast said regulators have granted their rare pediatric disease designation to its cell therapy Revascor for children with hypoplastic left heart syndrome. The Australian...

Mesoblast ADSs Plunge Premarket on Latest FDA Rejection

By Colin Kellaher American depositary shares of Mesoblast plummeted more than 65% in premarket trading Friday after the biopharmaceutical company's latest setback in its bid to win U.S. Food...

FDA Schedules Pre-License Inspection of Remestemcel-L Manufacturing

Biologics License Application (BLA) Resubmission for Pediatric Acute Graft-Versus-Host Disease (SR-aGVHD) Currently Being Reviewed PDUFA Goal Date August 2, 2023 If Approved, Remestemcel-L will be...

Mesoblast ADSs Rally as FDA Accepts Remestemcel-L Resubmission

By Colin Kellaher American depositary shares of Mesoblast Ltd. jumped more than 15% in early trading Wednesday after the biopharmaceutical company said the U.S. Food and Drug Administration...

Mesoblast Shares Rise 11% After Resubmitting Biologics License Application

By Chris Wack Mesoblast Ltd. shares were up 11% to $3.67 Wednesday after the company said it resubmitted a biologics license application to the U.S. Food and Drug Administration seeking approval...

Mesoblast Shares Rise 10% After New Info Submitted to FDA for Remestemcel-L

By Chris Wack Mesoblast Ltd. shares were up 10% to $2.80 after the company said it submitted substantial new information to the U.S. Food and Drug Administration on clinical and potency assay...

Mesoblast to Hold Type C Meeting With FDA for Back Pain Treatment

By Chris Wack Mesoblast Ltd. said it has filed a request and expects to hold a Type C meeting with the U.S. Food & Drug Administration during the current quarter to discuss the pathway to U.S...

Mesoblast Up 25% After Hours on Collaboration With Novartis

By Josh Beckerman Mesoblast Ltd. American depositary receipts surged 25% to $14.70 after hours as the company entered an exclusive worldwide license and collaboration agreement with Novartis AG...

Mesoblast Named Global Technology Leader in Cell Therapy Industry

Mesoblast Limited has been named by Frost & Sullivan as the 2017 Global Technology Leader in the Cell Therapy Industry. Mesoblast is a biopharma company specializing in cell...

Mesoblast’s Japan Licensee Receives Pricing for TEMCELL® HS Inj. for Treatment of Acute Graft Versus Host Disease

MELBOURNE, Australia and NEW YORK, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that its licensee in Japan, JCR Pharmaceuticals Co. Ltd., has...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.72401.83.091.8204070612.6005543DE
4165.78947368421.523.091.5102936142.15619985DE
121.39123.0088495581.133.091.1366240681.81809928DE
261.49144.6601941751.033.090.8860366961.44229354DE
522.227400.33.090.25571092251.06143556DE
1561.15584.61538461541.3653.090.25539703410.93035176DE
2600.5125.37313432842.015.70.25545179491.93926892DE

MSB - Frequently Asked Questions (FAQ)

What is the current Mesoblast share price?
The current share price of Mesoblast is AUD 2.52
How many Mesoblast shares are in issue?
Mesoblast has 736,578,315 shares in issue
What is the market cap of Mesoblast?
The market capitalisation of Mesoblast is AUD 1.77B
What is the 1 year trading range for Mesoblast share price?
Mesoblast has traded in the range of AUD 0.255 to AUD 3.09 during the past year
What is the PE ratio of Mesoblast?
The price to earnings ratio of Mesoblast is -21.11
What is the cash to sales ratio of Mesoblast?
The cash to sales ratio of Mesoblast is 200
What is the reporting currency for Mesoblast?
Mesoblast reports financial results in USD
What is the latest annual turnover for Mesoblast?
The latest annual turnover of Mesoblast is USD 9.25M
What is the latest annual profit for Mesoblast?
The latest annual profit of Mesoblast is USD -87.96M
What is the registered address of Mesoblast?
The registered address for Mesoblast is LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, 3000
What is the Mesoblast website address?
The website address for Mesoblast is www.mesoblast.com
Which industry sector does Mesoblast operate in?
Mesoblast operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RFGRetail Food Group Limited
AUD 2.49
(3,358.33%)
132.52k
QEMQEM Limited
AUD 0.055
(61.76%)
2.81M
MOMMoab Minerals Ltd
AUD 0.003
(50.00%)
183.33k
LM1Leeuwin Metals Ltd
AUD 0.145
(45.00%)
1.19M
VENVintage Energy Ltd
AUD 0.004
(33.33%)
13.31M
C29C29 Metals Limited
AUD 0.05
(-46.24%)
1.83M
SPXOASpenda Ltd
AUD 0.003
(-40.00%)
2M
NC6OBNanollose Limited
AUD 0.01
(-33.33%)
2.2k
GCRGolden Cross Resources Ltd
AUD 0.002
(-33.33%)
3.53M
ATHOAlterity Therapeutics Limited
AUD 0.002
(-33.33%)
1M
PERPercheron Therapeutics Ltd
AUD 0.0075
(0.00%)
35.97M
SITSite Group International Ltd
AUD 0.002
(0.00%)
33.46M
VPRVolt Group Ltd
AUD 0.002
(33.33%)
29.69M
BRNBrainchip Holdings Ltd
AUD 0.2975
(20.20%)
28.66M
TMGTrigg Minerals Ltd
AUD 0.042
(1.20%)
28.07M

Discussion

View Full Feed
sony12 sony12 5 minutes ago
Imo this is not a scam job like some say on here. Do you own DD
GRLT
ducci1 ducci1 7 minutes ago
ES & SPX 30 min still on Triple Cross Decline ( 20/50/233 EMA'S ) !
SPY
sony12 sony12 9 minutes ago
I TELL YOU WHERE THEY ARE…. MAKING MONEY NOT ON DEAD STOCKS LIKE YOU MAKING NOTHING IMO
ducci1 ducci1 13 minutes ago
Pivot Calcs:--SPX Pivot--5914----R1--5997----S1----5847-----ES Pivot--5968----R1__6071----S1--5890------VIX Pivot--20.89 !!LOL!!
SPY
JERSEYHAWG JERSEYHAWG 15 minutes ago
Thank you

Merry Christmas mates. To you and your family.

I sure hope this ends. It's been way to long.
LEHNQ
boi568 boi568 22 minutes ago
Assuming approval, I would expect strong year over year sales gains based on the interaction of likely customers (early AD and a high number of MCI) and the stickiness of the user base, supplemented each year by new customers who have developed early AD or MCI. The user base should be quite sticky
AVXL
ace65 ace65 25 minutes ago
Got 489k at .0008 a few weeks back..in the pot till .01+ with the rest.
ATWT
caddiedad caddiedad 26 minutes ago
Capt. You’re missing Lebanon. They approved years ago but we don't ever see any proof of revenues
AMRN
hweb2 hweb2 30 minutes ago
OT--Umm what is the point of this? Why are you reposting a BKTI post I made in August?? Btw you conveniently forgot all the posts where I thought BKTI was a steal in the low-mid teens. So I guess you're just trying to make me look bad? That's some gratitude for all the years I spent trying to he
nowwhat2 nowwhat2 30 minutes ago
https://investorshub.advfn.com/uimage/uploads/2024/12/23/tsrrhplby_888_12_logo_new_low_ma.jpg



LOCATE AUGUST 2024
https://investorshub.advfn.com/uimage/uploads/2024/12/23/hiibbplby_121212_4_4y_cup_girl.jpg



https://investorshub.advfn
PLBY
mauiguy2 mauiguy2 31 minutes ago
Gosh, that's really a good sign... a 1/2 million dollar purchase by a key executive close to the recent highs
SOFI
againstallodds againstallodds 36 minutes ago
Old posts about Iocann Pharma…

The then CEO of GNCP /Biocann Pharma had this to say about her demise, aboit conmen Stephen Lumb and Ronald Lowenthal…

https://investorshub.advfn.com/uimage/uploads/2024/12/23/wdyepIMG_1348.jpeg
GNCP
Chiugray Chiugray 36 minutes ago
Fluteman, Important point. I agree the probability for DCVax-L approval is around 95%.

That is a significant point because:
(AI Claude) Most high-risk investments (targeting very high rewards) have much lower probability profiles:
- Venture capital typically expects 7-8
NWBO
Zorax Zorax 41 minutes ago
I agree that mainstream media is a problem.
When I read this:
You guys just study news from one side and that's all. Need to look at the entire circumference to a situation.I thought this comment may have been so cerebral and of such high intelligence that it was totally over the hea
nowwhat2 nowwhat2 42 minutes ago
CORUS ENTERTAINMENT'S FIRST QUARTER FINANCIAL RESULTS TO BE RELEASED ON JANUARY 10, 2025

https://ih.advfn.com/stock-market/TSX/CJR.B/stock-news/95123446/corus-entertainments-first-quarter-financial-resul


https://bigcharts.marketwatch.com/advchart/frames/frames.a
CJR.B
prototype_101 prototype_101 44 minutes ago
Ha!! Too funny!! Do you understand that they could have built their own data centers too, then they could have put their own transceivers in their own data centers!!! You do realize how pathetic of an argument you are making?

The market for LWLG modulators is Huge Huge Huge in and of
LWLG
ORCA ORCA 46 minutes ago
THE INSIDERS KILLED BOTH STOCKS.AND DESTROYED SHARESHOLDERS VALUE.BUT A PAY BACK IS ON THE DECK.THEY HAVE NO FREAKEN IDEA THAT SOME TRADERS ARE ABSOLUTE DESTROYERS.FOR PAY BACK.I AM READY FOR ENORMOUS PAY BACK TO THESE SCAMBAGS.
SAML
nowwhat2 nowwhat2 46 minutes ago
https://investorshub.advfn.com/uimage/uploads/2024/12/23/oigbfusdcad_1_26_IPO_NEAT_PAR.jpg


https://investorshub.advfn.com/uimage/uploads/2024/12/23/fksxkusdcad_6_11_Hyper_USD_BO_DAY_w_PDM_CAT.jpg



https://investorshub.advfn.com/uimage/uploads/2024
USDCAD
ORCA ORCA 51 minutes ago
THESE CLOWNS THEY NEED TO STOP THE BLEEDING STARTING TOMORROW.OR IT GOES TO ZERO IN A HURRY.AND ALL THE CD CLOWNS LOSE ALL THEIR MONEY.VERY EASY TO KILL THE VOLUMES DOWN TO ZERO SCAMBAGS.NO ONE WILL BE TOUCHING THIS POS.SO TAKE YOUR HEADS OUT OF YOUR A$$ES AS EARLY AS TOMORROW A.M.YOU TOOK ALL TH
ES
copytele copytele 60 minutes ago
# 26 FOLLOW FOR YOU BUDDY , SHOT IT'S LOAD ? ````````````I DON'T THINK SO.
RGTI
SiliconValleyExec SiliconValleyExec 1 hour ago
You keep saying "Messiah." Was he rubbed with oil? Why do you keep saying he was rubbed with oil?
SEV
Zorax Zorax 1 hour ago
The article seems at odds with other events as I was under the assumption that iran has been supplying drones, arms and munitions to russia for over half the war against Ukraine.

If true, where's all that sales money? Or is iraq the supplier? No links or sources. Difference of one let
farml1234 farml1234 1 hour ago
what is the price of the funding per share?


jmho
ASPZ
nowwhat2 nowwhat2 1 hour ago
Gosh.....gee........

https://investorshub.advfn.com/uimage/uploads/2024/12/22/f[hrbBTC_121212_21_6M_8pm_XRP_WHY_SO_BOUNCY.jpg




https://investorshub.advfn.com/uimage/uploads/2024/12/22/kvwkzBTC_121212_21_45d_8PM_SEASON_GRINCH_MAG_CALV_100K.jpg
BTCUSD
Golden Cross Golden Cross 1 hour ago
Huge potential here!
TORVF

Your Recent History

Delayed Upgrade Clock